A male infant with Xq22.2q22.3 duplication containing PLP1 and MID2.
Swati R ChanchaniHongyan XieGurbax SekhonAna M MelikishviliSue Moyer HarasinkHarpreet PallPhilip F GiampietroPublished in: Molecular genetics & genomic medicine (2020)
Our patient's clinical features appear to be influenced by the PLP1 duplication but the clinical effect of other dosage sensitive genes influencing brain development cannot be ruled out.